644 - Effectiveness and safety of upadacitinib in adolescent…
Emerging
1
Citations0
Refs2024
Year
Search Works
Work Details
- DOI 10.1093/bjd/ljae266.024
- OpenAlex ID W4401435845
- Type Article
- Language EN
- Published 01 Aug 2024
- Volume 191 (Supplement_2)
- Source British Journal of Dermatology
- Publisher Oxford University Press
- FWCI 0.41
- Countries 1
- Institutions 5
- Added 09 Aug 2024
- Updated 26 Sep 2026
External Links
MENU
0
644 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an interim analysis of week 20-32 data from a real-world multicenter retrospective review
Article 2024 EN
Abstract Introduction While clinical trial data demonstrates the efficacy and safety of upadacitinib (UPA), a selective oral Janus kinase inhibitor (JAKi) for atopic dermatitis (AD), there is still a lack of real-world evidence. Objectives Our study evaluated the real-world effectiveness and safety of UPA for AD at weeks 20-32. Methods We conducted a multicenter retrospective review at three pract…
1
Citations
0
References
12
Authors
0.41
FWCI
Citations by Year
Last 1 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
12 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Brian D. Rankin | University of Calgary (CA) | |
| 2 | Siddhartha Sood | University of Toronto (CA) | |
| 3 | Ye‐Jean Park | University of Toronto (CA) | |
| 4 | Alexander N. Rimke | — | — |
| 5 | Abrahim Abduelmula | University of Toronto (CA) | |
| 6 | Jorge R. Georgakopoulos | University of Toronto (CA) | |
| 7 | Khalad Maliyar | University of Toronto (CA) | |
| 8 | Fernejoy Leung | — | — |
| 9 | Lauren A. Stark | — | — |
| 10 | Alim R Devani | Probity Medical Research (CA) | — |
| 11 | Jensen Yeung | Sunnybrook Health Science Cent… (CA) Women's College Hospital (CA) +1 | |
| 12 | Vimal H. Prajapati | University of Calgary (CA) Probity Medical Research (CA) |
Related Works
10Data: OpenAlex